Last week, Alphabet subsidiary Verily Life Sciences announced the end, at least for the foreseeable future, of its glucose-sensing contact lens collaboration with Novartis.
Verily CTO Brian Otis gave his thoughts in a blog post at the time, stressing the learnings the company got from the project. In a recent interview with MobiHealthNews, Novartis Global Head of Digital Development Jacob LaPorte...
Women's health technology company Kindara has had another executive shakeup, naming a new CEO, CTO, and EVP. The new CEO, Ira Hernowitz, previously served as president of children's footwear company Stride Rite. The company also announced a new Chief Technology Officer, Malte Muenke, and a new EVP, Raychel Muenke, both of whom previously worked at Citrix.
“The newly appointed members of Kindara’...
Three bits of news this week from companies working on diabetes management offerings might be of interest to anyone interested in digital health.
First off, NovioSense, a Dutch company developing a smartphone-connected tear-based glucose sensor that sits in the lower eyelid, secured an undisclosed amount of new funding. The round included existing investors Health Innovations, Topfonds...
NovioSense's glucose sensor.
A new joint venture made up of two American and two European companies will aim to use near-field communication (NFC) technology to create new options for diabetes management. The Mayo Clinic and Washington, DC-based medical technology company Gentag will form the American half of the venture, while Dutch medical technology company NovioSense and German R&D...
